LuminX

LuminX is a medical technology company redefining dental diagnostics through an intelligent, AI-driven platform designed to detect early-stage oral disease with far greater accuracy and efficiency. Global evidence shows that both hard-tissue and soft-tissue dental diseases are routinely diagnosed too late. Most tooth decay remains untreated until substantial damage has occurred, and gum disease often goes unnoticed until it has already caused bone loss or tooth mobility.

The widespread prevalence of untreated cavities and severe periodontitis illustrates systemic late detection. Several forces drive this: a reactive, procedure-driven culture that rewards treatment over prevention; diagnostic workflows that are constrained, subjective, rushed, and highly dependent on scarce personnel; and the inherently manual and error-prone nature of traditional diagnostic methods. When assessment depends on clinician judgment rather than objective measurement, early lesions are frequently missed, allowing decay and periodontal disease to advance before they are recognized.

LuminX fills this critical gap with the LuminX Probe, a proprietary multi-agent AI platform integrating computational optics, structured light, probe-mounted 3D cameras, and deep learning. The system enables a single clinician to complete a full-mouth periodontal exam in under five minutes, automatically capturing pocket depths, bleeding, and calculus alongside photographic proof. This improves diagnostic precision, increases insurance approval rates, and enhances patient understanding through real-time imagery and intuitive educational tools.

Backed by 60 filed patents (39 granted or allowed) and an experienced leadership team, LuminX is positioned for international impact. With a robust product roadmap, a PaaS business model, and regulatory plans targeting a 2026 U.S. launch, LuminX is poised to become the new standard of care in dental diagnostics.